Balyasny Asset Management
AMED

Balyasny Asset Management’s Amedisys AMED Stock Holding History

Balyasny Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-641,299
Closed -$63.1M – 2876
2025
Q2 		$63.1M Buy
641,299
+54,037
+9% +$5.11M 0.1% 255
2025
Q1 		$54.4M Buy
587,262
+170,566
+41% +$15.7M 0.09% 276
2024
Q4 		$37.8M Sell
416,696
-57,576
-12% -$5.29M 0.06% 417
2024
Q3 		$45.8M Buy
474,272
+434,663
+1,097% +$42.4M 0.07% 340
2024
Q2 		$3.64M Buy
+39,609
New +$3.68M 0.01% 1316
2023
Q4 		– Sell
-27,500
Closed -$2.57M – 2463
2023
Q3 		$2.57M Buy
+27,500
New +$2.54M 0.01% 1316
2020
Q2 		– Sell
-19,794
Closed -$3.63M – 1100
2020
Q1 		$3.63M Sell
19,794
-903
-4% -$161K 0.04% 479
2019
Q4 		$3.46M Sell
20,697
-105,943
-84% -$15.8M 0.02% 656
2019
Q3 		$16.6M Buy
+126,640
New +$16.5M 0.11% 269
2019
Q2 		– Sell
-12,267
Closed -$1.51M – 1451
2019
Q1 		$1.51M Sell
12,267
-1,400
-10% -$176K 0.01% 899
2018
Q4 		$1.6M Sell
13,667
-40,406
-75% -$4.76M 0.01% 768
2018
Q3 		$6.76M Sell
54,073
-33,889
-39% -$3.74M 0.03% 604
2018
Q2 		$7.52M Sell
87,962
-165,180
-65% -$12.1M 0.03% 566
2018
Q1 		$15.3M Buy
253,142
+222,964
+739% +$12.7M 0.06% 399
2017
Q4 		$1.59M Buy
30,178
+18,652
+162% +$983K 0.01% 1208
2017
Q3 		$645K Sell
11,526
-111,636
-91% -$5.9M ﹤0.01% 1273
2017
Q2 		$7.74M Buy
+123,162
New +$7.17M 0.03% 620

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balyasny Asset Management's AMED Position: Q3 2025 in Review

Balyasny Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 641,299 shares — an estimated $63.1M sold.

Balyasny Asset Management first reported a position in AMED in Q2 2017 and held it in 17 quarters. The position peaked at $63.1M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Balyasny Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 641,299 Amedisys shares in Q3 2025, an estimated $63.1M.
  • Balyasny Asset Management first reported a position in Amedisys in Q2 2017 and held it in 17 quarters.
  • Balyasny Asset Management's Amedisys position peaked at $63.1M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.